Psychotropic drug repurposing for COVID-19: a systematic review
Introduction Recently, several antidepressants, mood stabilizers, and antipsychotics have been suggested to have favorable effects in the treatment of COVID-19. Objectives The aim of this systematic review was to collect evidence from preclinical and clinical studies concerning the scientific evid...
Main Authors: | U. Isayeva, G. Fico, S. Gomes-Da-Costa, M. Sagué Villavella, A. Gimenez, M. Manchia, A. Murru |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822008574/type/journal_article |
Similar Items
-
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
by: Marina Caldara, et al.
Published: (2021-09-01) -
Determination of Serum/Plasma Concentrations of Psychotropic Drugs in Therapeutic Drug Monitoring
by: I. I. Miroshnichenko, et al.
Published: (2021-09-01) -
Influence of psychotropic drugs on driving skils
by: Brigita Novak Šarotar, et al.
Published: (2013-02-01) -
Discontinuing psychotropic drug treatment
by: Leonardo Tondo, et al.
Published: (2020-03-01) -
Repurposing Antipsychotics for Cancer Treatment
by: Nikolaos Vlachos, et al.
Published: (2021-11-01)